Mathematical modeling of leukemogenesis and cancer stem cell dynamics

Mathematical Modelling of Natural Phenomena

Volumn 7, Issue 1, 2012, Pages 166-202

  Stiehl, T ^a   Marciniak Czochra, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer stem cells; Environmental signaling; Leukemia; Leukemic stem cells; Linear stability analysis; Multi compartmental models; Stem cell differentiation

Indexed keywords

BIOMEDICAL RESEARCH; CANCER STEM CELLS; CELLULAR PROPERTIES; LEUKEMIA; LEUKEMOGENESIS; LINEAR STABILITY; MALIGNANT CELLS; MATHEMATICAL MODELING; STEM CELL DIFFERENTIATION;

DISEASES; DYNAMICS; LINEAR STABILITY ANALYSIS; MATHEMATICAL MODELS; STEM CELLS;

CLONE CELLS;

EID: 84856490132     PISSN: 09735348     EISSN: 17606101     Source Type: Journal    
DOI: 10.1051/mmnp/20127199     Document Type: Article

References (67)

1. J. Ablain, H. de The. Revisiting the differentiation paradigm in acute promyelocytic leukemia. Blood, 117 (2008), No. 22, 5795-5802.
2. M. Adimy, F. Crauste. Modeling and asymptotic stability of a growth factor-dependent stem cell dynamics model with distributed delay. Discrete Contin. Dyn. Syst. Ser. B, 8 (2007), No. 1, 19-38.
3. M. Adimy, F. Crauste, S. Ruan. A mathematical study of the hematopoiesis process with applications to chronic myelogenous leukemia. SIAM J. Appl. Math., 65 (2005), No. 4, 1328-1352. (Pubitemid 41343748)
4. M. Adimy, F. Crauste, S. Ruan. Modelling hematopoiesis mediated by growth factors with applications to periodic hematological diseases. Bull. Math. Biol., 68 (2006), No. 8, 2321-2351.
5. M. Aglietta, W. Piacibello, F. Sanavio, A. Stacchini, F. Apra, M. Schena, C. Mossetti, F. Carnino, F. Caligaris-Cappio, F. Gavosto. Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. J. Clin. Invest., 83 (1989), No. 2, 551-557. (Pubitemid 19061177)
6. T. Alarcon, P. Getto, A. Marciniak-Czochra, MdM. Vivanco. A model for stem cell population dynamics with regulated maturation delay. Discr. Cont. Dyn. Systems B (2011),
7. to appear. L. Andrey. Chaos in cancer. Med. Hypotheses, 28 (1989), No. 3, 143-144. (Pubitemid 19068458)
8. O. Arino, M. Kimmel. Stability analysis of models of cell production systems. Math. Modelling, 7 (1986), No. 9-12, 1269-1300.
9. M. Baum, MA. Chaplain, AR. Anderson, M. Douek, JS. Vaidya. Does breast cancer exist in a state of chaos? Eur. J. Cancer, 35 (1999), No. 6, 886-891. (Pubitemid 29277120)
10. R. Bejar, R. Levine, and B. L. Ebert. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J. Clin. Oncol., 29 (2011), No. 5, 504-514.
11. J. Belair, MC. Mackey, J. M. Mahaffy. Age-structured and two-delay models for erythropoiesis. Math. Biosci., 128 (1995), No. 1-2, 317-346.
12. C. Bellan, L. Stefano, dF. Giulia, E. A. Rogena, L. Lorenzo. Burkitt lymphoma versus diffuse large B-cell lymphoma : a practical approach. Hematol. Oncol., 28 (2010), No. 2, 53-56.
13. MT. Bocker, I. Hellwig, A. Breiling, V. Eckstein, A. D. Ho, F. Lyko. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood, 117 (2011), No. 19 : e182-e189.
14. V. Bogner, L. Keil, KG. Kanz, C. Kirchhoff, B. A. Leidel, W. Mutschler, P. Biberthaler. Very early posttraumatic serum alterations are signiïćantly associated to initial massive RBC substitution, injury severity, multiple organ failure and adverse clinical outcome in multiple injured patients. Eur. J. Med. Res., 14 (2009), No. 7, 284-291.
15. D. Bonnet, J. E. Dick. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med., 3 (1997), No. 7, 730-737. (Pubitemid 27298715)
16. J. Bryan, E. Jabbour, H. Prescott, G. Garcia-Manero, J. P. Issa, H. Kantarjian. Current and future management options for myelodysplastic syndromes. Drugs, 70 (2010), No. 11, 1381-1394.
17. EC. Buss, A. D. Ho. Leukemia stem cells. Int. J. Cancer., 129 (2011), No. 10, 2328-2336.
18. SY. Chen, YC. Huang, SP Liu, FJ Tsai, WC Shyu, SZ Lin. An overview of concepts for cancer stem cells. Cell Transplant., 20 (2011), No. 1, 113-120.
19. BD. Cheson. Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes. Leuk. Res., Suppl. 1 (1998), S17-S21.
20. H. Clevers. The cancer stem cell : premises, promises and challenges. Nat Med., 17 (2011), No. 3, 313-319.
21. D. S. Coffey. Self-organization, complexity and chaos : the new biology for medicine. Nat. Med., 4 (1998), No. 8, 882-885. (Pubitemid 28364016)
22. C. Colijn, M. C. Mackey. A mathematical model of hematopoiesis-I. periodic chronic myelogenous leukemia. J. Theor. Biol., 237 (2005), No. 2, 117-132. (Pubitemid 41406400)
23. D. Dingli, JM. Pacheco. Stochastic dynamics and the evolution of mutations in stem cells. BMC Biol., 9 :41 (2011).
24. M. Doumic-Jauffret, PS. Kim, B. Perthame. Stability analysis of a simplied yet complete model for chronic myelogenous leukemia. Bull. Math. Biol., 72 (2010), No. 7, 1732-1759.
25. M. Doumic-Jauffret, A. Marciniak-Czochra, B. Perthame, JP. Zubelli. A Structured Population Model of Cell Differentiation. SIAM J. Appl. Math., 71 (2011), 1918-1940.
26. P. Fenaux, GJ. Mufti, E. Hellstrom-Lindberg, V. Santini, C. Finelli, A. Giagounidis, R. Schoch, N. Gattermann, G. Sanz, A. List, SD. Gore, JF. Seymour, JM. Bennett, J. Byrd, J. Backstrom, L. Zimmerman, D. McKenzie, C. Beach, LR. Silverman; International Vidaza High-Risk MDS Survival Study Group. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes : a randomised, open-label, phase III study. Lancet Oncol., 10 (2009), No. 3, 223-232.
27. C. Foley, S. Bernard, MC. Mackey. Cost-effective G-CSF therapy strategies for cyclical neutropenia : Mathematical modelling based hypotheses. J. Theor. Biol., 238 (2006), No. 4, 754-763. (Pubitemid 43175826)
28. W. Fried. Erythropoietin and erythropoiesis. Exp. Hematol., 37 (2009), No. 9, 1007-1015.
29. FR. Gantmacher. The theory of matrices 2. Chelsea Publishing, New York, 1964.
30. P. Getto, A. Marciniak-Czochra, Y. Nakata, MdM. Vivanco. Global dynamics of two compartment models for cell production systems with regulatory mechanisms. (2011), submitted.
31. J. Guckenheimer, P. Holmes. Nonlinear Oscillations, Dynamical Systems, and Bifurcations of Vector Fields. Springer, New York, 2002.
32. H. Haeno, RL. Levine, DG. Gilliland, F. Michor. A progenitor cell origin of myeloid malignancies. PNAS, 106 (2009), No. 39, 16616-16621.
33. KJ. Hope, L. Jin, JE. Dick. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immun., 5 (2004), No. 7, 738-743. (Pubitemid 39023306)
34. JH. Jandl (ed), Textbook of Hematology, Little Brown, Boston, MA, 1996.
35. S. Janz, M. Potter, CS. Rabkin. Lymphoma-and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer, 36 (2003), No. 3, 211-223. (Pubitemid 36158194)
36. H. Kantarjian, Y. Oki, G. Garcia-Manero, X. Huang, S. OBrien, J. Cortes, S. Faderl, C. Bueso-Ramos, F. Ravandi, Z. Estrov, A. Ferrajoli, W. Wierda, J. Shan, J. Davis, F. Giles, HI. Saba, JP. Issa. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood, 109 (2007), No. 1, 52-57. (Pubitemid 46053042)
37. S. Knipp, B. Hildebrand, A. Kündgen, A. Giagounidis, G. Kobbe, R. Haas, C. Aul, N. Gat-termann, U. Germing. Intensive chemotherapy is not recommended for patients aged > 60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes. Cancer, 110 (2007), No. 2, 345-352. (Pubitemid 47121895)
38. N. Korde, SY. Kristinsson, O. Landgren. Monoclonal gammopathy of undetermined signiïćance (MGUS) and smoldering multiple myeloma (Smm) : novel biological insights and development of early treatment strategies. Blood, 117 (2011), No. 21, 5573-5581.
39. A. Lander, K. Gokoffski, F. Wan, Q. Nie, A. Calof. Cell lineages and the logic of proliferative control. PLoS biology, 7 (2009), No. 1, 84-100.
40. SS. Lange, K. Takata, RD. Wood. DNA polymerases and cancer. Nat. Rev. Cancer, 11 (2011), No. 2, 96-110.
41. PM. Lansdorp. Stem cell biology for the transfusionist. Vox Sang., 74 Suppl. 2 (1998), 91-94.
42. JE. Layton, H. Hockman, WP. Sheridan, G. Morstyn. Evidence for a novel in vivo control mechanism of granulopoiesis : mature cell-related control of a regulatory growth factor. Blood, 74 (1989), No. 4, 1303-1307. (Pubitemid 19227439)
43. W. Lo, C. Chou, K. Gokoffski, F. Wan, A. Lander, A. Calof, Q. Nie. Feedback regulation in multistage cell lineages. Math. Biosci. Eng., 6 (2009), No. 1, 59-82.
44. MC. Mackey. Unified hypothesis for the origin of aplastic anemia and periodic hematopoiesis. Blood, 51 (1978), No. 5, 941-956.
45. MC. Mackey, L. Glass, Oscillation and chaos in physiological control systems. Science, 197 (1977), No. 4300, 287-289. (Pubitemid 8130447)
46. A. Marciniak-Czochra, T. Stiehl. Mathematical models of hematopoietic reconstitution after stem cell transplantation. In HG. Bock, T. Carraro, W. Jäger, S. Koerkel, R. Rannacher, JP. Schloeder (eds), Model Based Parameter Estimation : Theory and Applications. Springer, Heidelberg, 2011.
47. A. Marciniak-Czochra, T. Stiehl, W. Jäger, AD. Ho, W. Wagner. Modeling of asymmetric cell division in hematopoietic stem cells-regulation of self-renewal is essential for efficient repopulation. Stem Cells Dev., 18 (2009), No. 3, 377-385.
48. A. Marciniak-Czochra, T. Stiehl, W. Wagner. Modeling of replicative senescence in hematopoietic development. Aging (Albany NY), 1 (2009), No. 8, 723-732.
49. D. Metcalf. Hematopoietic cytokines. Blood, 111 (2008), No. 2, 485-491.
50. F. Michor, TP. Hughes, Y. Iwasa, S. Branford, NP. Shah, CL. Sawyers, MA. Nowak. Dynamics of chronic myeloid leukaemia. Nature, 435 (2005), No. 7046, 1267-1270. (Pubitemid 40943094)
51. KA. Moore, IR. Lemischka. Stem cells and their niches. Science, 311 (2006), No. 5769, 1880-1805.
52. D. Morgan, A. Murray, T. Hunt, P. Nurse. In : Alberts Molecular Biology of the Cell, 4th Edition, Garland Science, New York, 2002.
53. I. Munk Pedersen, J. Reed. Microenvironmental interactions and survival of CLL B-cells. Leuk. Lymphoma, 45 (2004), No. 12, 2365-2372. (Pubitemid 40081179)
54. Y. Nakata, P. Getto, A. Marciniak-Czochra, T. Alarcon. Stability analysis of multi-compartment models for cell production systems. J. Biol. Dyn., (2011), doi : 10. 1080/17513758. 2011. 558214.
55. L. Pujo-Menjouet, S. Bernard, MC. Mackey. Long period oscillations in a G0 model of hematopoietic stem cells. SIAM J. Appl. Dyn. Syst, 4 (2005), No. 2, 312-332. (Pubitemid 43385177)
56. T. Reya, SJ. Morrison, MF. Clarke, IL. Weissman. Stem cells, cancer, and cancer stem cells. Nature, 414 (2001), No. 6859, 105-111. (Pubitemid 33041634)
57. I. Roeder, M. Herberg, M. Horn. An age-structured model of hematopoietic stem cell organization with application to chronic myeloid leukemia. Bull. Math. Biol., 71 (2009), No. 3, 602-626.
58. I. Roeder, M. Horn, I. Glauche, A. Hochhaus, MC. Mueller, M. Loeffler. Dynamic modeling of imatinib-treated chronic myeloid leukemia : functional insights and clinical implications. Nat. Med., 12 (2006), No. 10, 1181-1184. (Pubitemid 44527354)
59. I. Roeder, M. Loeffler. A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity. Exp. Hematol., 30 (2002), 853-861. (Pubitemid 34851245)
60. R. Rudnicki. Chaoticity of the blood cell production system. Chaos, doi : 10. 1063/1. 3258364, 2009.
61. F. Schueler, C. Hirt, G. Doelken. Chromosomal translocation t (14′18) in healthy individuals. Semin. Cancer. Biol., 13 (2003), 3, 203-209. (Pubitemid 36577692)
62. K. Shinjo, A. Takeshita, K. Ohnishi, R. Ohno. Granulocyte colony-stimulating factor receptor at various stages of normal and leukemic hematopoietic cells. Leuk. Lymphoma, 25 (1997), No. 1-2, 37-46. (Pubitemid 27165649)
63. S. Soltanian, MM. Matin. Cancer stem cells and cancer therapy. Tumour Biol., 32 (2011), No. 3, 425-440.
64. T. Stiehl, A. Marciniak-Czochra. Characterization of stem cells using mathematical models of multistage cell lineages. Mathematical and Computer Modelling, 53 (2011), No. 7-8, 1505-1517.
65. JE. Till, L. Siminovitch, EA. McCulloch. Stochastic Model of Stem Cell Proliferation Based on Growth of Spleen Colony-Forming Cells. PNAS, 51 (1964), 29-49.
66. C. Tomasetti, D. Levy. Role of symmetric and asymmetric division of stem cells in developing drug resistance. PNAS., 107 (2010), No. 39. 16766-16771.
67. M. Tormo, I. Marugan, M. Calabuig. Myelodysplastic syndromes : an update on molecular pathology. Clin. Transl. Oncol., 12 (2010), No. 10, 652-661.